BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29111437)

  • 1. A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approaches.
    Legeron R; Xuereb F; Chaignepain S; Gadeau AP; Claverol S; Dupuy JW; Djabarouti S; Couffinhal T; Schmitter JM; Breilh D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():43-53. PubMed ID: 29111437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
    Li W; Lin H; Fu Y; Flarakos J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits.
    Truffot A; Jourdil JF; Seitz-Polski B; Malvezzi P; Brglez V; Stanke-Labesque F; Gautier-Veyret E
    Clin Biochem; 2021 Jan; 87():60-66. PubMed ID: 33096054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human plasma.
    Chiu HH; Tsai IL; Lu YS; Lin CH; Kuo CH
    Anal Bioanal Chem; 2017 Nov; 409(28):6583-6593. PubMed ID: 28963670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.
    Faria M; Halquist MS; Yuan M; Mylott W; Jenkins RG; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():156-68. PubMed ID: 26279007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.
    Heudi O; Barteau S; Zimmer D; Schmidt J; Bill K; Lehmann N; Bauer C; Kretz O
    Anal Chem; 2008 Jun; 80(11):4200-7. PubMed ID: 18465883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS.
    Chiu HH; Liao HW; Shao YY; Lu YS; Lin CH; Tsai IL; Kuo CH
    Anal Chim Acta; 2018 Aug; 1019():93-102. PubMed ID: 29625688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of free sialic acid in human plasma through a robust quinoxalinone derivatization and LC-MS/MS using isotope-labeled standard calibration.
    Wang D; Zhou X; Wang L; Wang S; Sun XL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():75-81. PubMed ID: 24291723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioanalytical Techniques Between LC-MS/MS, ELISA, and Microfluidic-based Immunoassay.
    Iwamoto N; Takanashi M; Shimada T; Sasaki J; Hamada A
    AAPS J; 2019 Aug; 21(6):101. PubMed ID: 31432293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry.
    Bronsema KJ; Bischoff R; van de Merbel NC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():1-14. PubMed ID: 22426285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The flexibility of a generic LC-MS/MS method for the quantitative analysis of therapeutic proteins based on human immunoglobulin G and related constructs in animal studies.
    Lanshoeft C; Wolf T; Walles M; Barteau S; Picard F; Kretz O; Cianférani S; Heudi O
    J Pharm Biomed Anal; 2016 Nov; 131():214-222. PubMed ID: 27599352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case study.
    Peng K; Xu K; Liu L; Hendricks R; Delarosa R; Erickson R; Budha N; Leabman M; Song A; Kaur S; Fischer SK
    MAbs; 2014; 6(6):1500-8. PubMed ID: 25484037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K; Manibusan A; Marsden R; Pinkstaff J
    J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody drug quantitation in coexistence with anti-drug antibodies on nSMOL bioanalysis.
    Iwamoto N; Hamada A; Shimada T
    Anal Biochem; 2018 Jan; 540-541():30-37. PubMed ID: 29128290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?
    Jourdil JF; Lebert D; Gautier-Veyret E; Lemaitre F; Bonaz B; Picard G; Tonini J; Stanke-Labesque F
    Anal Bioanal Chem; 2017 Feb; 409(5):1195-1205. PubMed ID: 27826630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples.
    Zhang Y; Li N; Brown PW; Ozer JS; Lai Y
    Rapid Commun Mass Spectrom; 2011 Jun; 25(12):1715-24. PubMed ID: 21598331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of pinostrobin in rat plasma by LC-MS/MS: application to pharmacokinetics.
    Hua X; Fu YJ; Zu YG; Zhang L; Wang W; Luo M
    J Pharm Biomed Anal; 2011 Dec; 56(4):841-5. PubMed ID: 21840667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS/MS quantification of 7α-hydroxy-4-cholesten-3-one (C4) in rat and monkey plasma.
    Kang L; Connolly TM; Weng N; Jian W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1064():49-55. PubMed ID: 28915417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method.
    El Amrani M; van den Broek MP; Göbel C; van Maarseveen EM
    J Chromatogr A; 2016 Jul; 1454():42-8. PubMed ID: 27264745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of an LC-MS/MS method for the simultaneous quantification of human intestinal transporter proteins absolute abundance using a QconCAT technique.
    Harwood MD; Achour B; Russell MR; Carlson GL; Warhurst G; Rostami-Hodjegan A
    J Pharm Biomed Anal; 2015 Jun; 110():27-33. PubMed ID: 25796981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.